Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
US-2026091033-A1 · Apr 2, 2026 · US
Munnich Arnold is listed as an inventor on 21 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Munnich Arnold |
| Total patents | 21 |
| First publication | Feb 24, 2015 |
| Latest publication | Apr 2, 2026 |
Publications ranked by popularity score, then publication date.
US-2026091033-A1 · Apr 2, 2026 · US
US-2024350490-A1 · Oct 24, 2024 · US
US-2024117344-A1 · Apr 11, 2024 · US
US-11857532-B2 · Jan 2, 2024 · US
US-11667913-B2 · Jun 6, 2023 · US
US-2023075776-A1 · Mar 9, 2023 · US
US-11357778-B2 · Jun 14, 2022 · US
US-2022105073-A1 · Apr 7, 2022 · US
US-2022031696-A9 · Feb 3, 2022 · US
US-2020246337-A1 · Aug 6, 2020 · US
Latest publications not already listed above.
US-2019037583-A2 · Jan 31, 2019 · US
US-2018161327-A1 · Jun 14, 2018 · US
US-9931341-B2 · Apr 3, 2018 · US
US-9834820-B2 · Dec 5, 2017 · US
US-2016369348-A1 · Dec 22, 2016 · US
US-2016150555-A1 · May 26, 2016 · US
US-2016051549-A1 · Feb 25, 2016 · US
US-2016032382-A1 · Feb 4, 2016 · US
US-2015106960-A1 · Apr 16, 2015 · US
US-2015104437-A1 · Apr 16, 2015 · US
US-8962269-B2 · Feb 24, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Inst Nat Sante Rech Med | 18 |
| Univ Paris Descartes | 9 |
| Imagine | 9 |
| Centre Nat Rech Scient | 8 |
| Hopitaux Paris Assist Publique | 7 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/506 | 9 |
| B29K2035/00 | 9 |
| A61K38/179 | 9 |
| A61K38/177 | 9 |
| A61K31/519 | 9 |